在治疗政策策略中,适应性归算缺失数据的方法,用于稀疏地获取治疗政策策略中的学
Chuanji Yuan1, Zhenyu Yang2, Jiaqing Liu1
1Department of Pharmaceutical informatics, School of Shenyang Pharmaceutical University, Shenyang, 110016, Liaoning, China.
Contemporary clinical trials
|March 22, 2025
概括
本研究引入了一种适应模型,以改善缺少数据的临床试验的统计分析. 这种新的方法最大限度地降低了差异通货膨胀,确保准确的结果,即使只有很少的取回放弃.
科学领域:
- 临床试验方法论 临床试验方法论
- 医学中的统计分析.
- 药学研究 药学研究
背景情况:
- ICH E9 R1 附录建议在临床试验中处理间流事件的治疗政策策略.
- 恢复的脱离者是停止治疗但完成终点评估的参与者,而早期退出导致数据丢失.
- 现有的方法,如混合效应模型和检索失败归算,可以减轻缺失的数据,但如果检索失败很少,可能会膨胀差异.
研究的目的:
- 引入和评估用于临床试验的创新自适应统计模型.
- 为了解决在回收掉机方法中变异膨胀的问题,当回收掉机的数量很低时.
- 为了确保准确估计事实上的估计,在存在间流动事件和缺失数据的情况下.
主要方法:
- 开发一个自适应模型,使用残余 (RD_OICSR) 模型来完善使用常见斜坡的开/关截面.
- 使用来自抑郁症临床试验的模拟数据对适应模型的评估.
- 纳入安慰剂补充剂的数据,以尽量减少变异膨胀,当检索的退学者低于预定义的门时.
主要成果:
- 拟议的自适应模型有效地将不切实际的差异通胀降到最低,当被检索的退学者的比例低于研究人员定义的值时.
- 该模型适应地与RD_OICSR模型保持一致,确保准确的分析,无论所检索的失业者比例如何.
- 来自抑郁症试验的模拟数据证明了模型保持分析准确性的能力.
结论:
- 这种新型的自适应模型提供了对现有的检索失学方法的改进,用于处理临床试验中缺少的数据.
- 这种方法确保了可靠和准确的统计分析,特别是在回收的中断人数较少的场景中.
- 该方法提供了一种可靠的策略来估计事实上的估计,从而提高临床试验结果的完整性.
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
23
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
23
Strategies for Assessing and Addressing Confounding
77
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
77
Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Assumptions of Survival Analysis
77
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
77
Censoring Survival Data
55
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
55
Kaplan-Meier Approach
71
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
71


